Denosumab: Experimental Drug Helps Ward Off Osteoporosis

An experimental drug has successfully reduced hip and spine fractures in the two largest patient populations at risk for osteoporosis — postmenopausal women and men being treated for prostate cancer — according to two major studies published online on Aug. 11 by the New England Journal of Medicine

Share